Post by
Spear2000 on Apr 26, 2016 4:34pm
Valeant is a Buy
They could sell off one business unit for 20 billion, pay off 2/3 of their debt, and only take a 25% hit to their bottom line. There are so many ways they could do this. This company is making like 8-11 billion in revenue per year, and its market cap is 12 billion. All the metrics point towards a buy. Congress is not going to tell businesses they cant raise the price on their products no matter how much they dont like it. That would be a huge blow to the innovation/incentive of the pharmaseutical industry. It going to be a yelling match, and then Valeant is going to continue to make billions.
Comment by
blindowlscout on Apr 26, 2016 4:37pm
Agree, you are talking common sense...in a couple weeks after all the noise Valeant will be out of the news and back to regular business. will be trading north of $60 shortly...enjoy the ride.
Comment by
wallop13 on Apr 26, 2016 6:35pm
You better believe it. Bausch & Lomb is an awesome asset. It's the number one vision care brand in China with 28% of the market and it's the fastest growing vision care brand there. With a billion people in China can you imagine what that is worth. Who wouldn't want that?